Potential cost savings of a wound bed-conforming silicone foam dressing with 3DFit Technology compared with standard of care.

IF 1.7 4区医学 Q3 DERMATOLOGY

Journal of wound care Pub Date : 2025-09-02 DOI:10.12968/jowc.2025.0291

Caroline Dowsett, Julie Beck Christoffersen, Mette Irene Agerkvist Hansen, Paddy Markey

{"title":"Potential cost savings of a wound bed-conforming silicone foam dressing with 3DFit Technology compared with standard of care.","authors":"Caroline Dowsett, Julie Beck Christoffersen, Mette Irene Agerkvist Hansen, Paddy Markey","doi":"10.12968/jowc.2025.0291","DOIUrl":null,"url":null,"abstract":"Objective: The increasing prevalence of chronic wounds, particularly venous leg ulcers (VLUs) and diabetic foot ulcers (DFUs), presents significant clinical and economic challenges within the National Health Service in the UK. This study was designed to evaluate the financial impact of replacing the standard of care (SoC), two-dressing regimen with a single silicone foam dressing with 3DFit Technology, Biatain Silicone (Coloplast, UK), in the treatment of these wounds in the community setting in the UK.Method: A budget impact model was developed to estimate the potential cost savings of a progressive transition from SoC to the single silicone foam dressing with 3DFit Technology over a five-year horizon. The target group was estimated based on current population data, an estimation of the population with VLUs and DFUs, and finally the wound eligibility criteria for using Biatain Silicone. The model was created from a payer perspective. A conservative approach was taken in estimating the target population, annual growth rate, unit cost and uptake rate.Results: The model indicated potential cost savings of £5.1 million by switching from the two-dressing regimen to the single silicone foam dressing with 3DFit Technology for patients with VLUs and DFUs over a five-year period.Conclusion: This study indicated potential cost savings by transitioning from SoC to a single silicone foam dressing with 3DFit Technology in the treatment of patients with VLUs and DFUs without compromising the clinical outcomes in wound management.","PeriodicalId":17590,"journal":{"name":"Journal of wound care","volume":"34 9","pages":"724-730"},"PeriodicalIF":1.7000,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of wound care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12968/jowc.2025.0291","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: The increasing prevalence of chronic wounds, particularly venous leg ulcers (VLUs) and diabetic foot ulcers (DFUs), presents significant clinical and economic challenges within the National Health Service in the UK. This study was designed to evaluate the financial impact of replacing the standard of care (SoC), two-dressing regimen with a single silicone foam dressing with 3DFit Technology, Biatain Silicone (Coloplast, UK), in the treatment of these wounds in the community setting in the UK.

Method: A budget impact model was developed to estimate the potential cost savings of a progressive transition from SoC to the single silicone foam dressing with 3DFit Technology over a five-year horizon. The target group was estimated based on current population data, an estimation of the population with VLUs and DFUs, and finally the wound eligibility criteria for using Biatain Silicone. The model was created from a payer perspective. A conservative approach was taken in estimating the target population, annual growth rate, unit cost and uptake rate.

Results: The model indicated potential cost savings of £5.1 million by switching from the two-dressing regimen to the single silicone foam dressing with 3DFit Technology for patients with VLUs and DFUs over a five-year period.

Conclusion: This study indicated potential cost savings by transitioning from SoC to a single silicone foam dressing with 3DFit Technology in the treatment of patients with VLUs and DFUs without compromising the clinical outcomes in wound management.

查看原文本刊更多论文

与标准护理相比，采用3DFit技术的符合伤口床的硅胶泡沫敷料的潜在成本节约。

目的：慢性伤口，特别是下肢静脉溃疡（VLUs）和糖尿病足溃疡（DFUs）的患病率日益增加，在英国国家卫生服务中提出了重大的临床和经济挑战。本研究旨在评估用3DFit技术Biatain silicone（康乐保，英国）的单硅胶泡沫敷料取代标准护理（SoC）的双重敷料方案对英国社区环境中这些伤口治疗的财务影响。方法：开发了一个预算影响模型，以估计3DFit技术在五年内从SoC逐步过渡到单一硅胶泡沫敷料的潜在成本节约。目标人群的估计是基于当前人群数据，对vlu和dfu人群的估计，最后是使用Biatain硅胶的伤口资格标准。该模型是从付款人的角度创建的。在估计目标人口、年增长率、单位成本和吸收率方面采取保守方法。结果：该模型表明，对于患有vlu和dfu的患者，在五年内，通过将两种敷料方案转换为使用3DFit技术的单硅胶泡沫敷料，可以节省510万英镑的潜在成本。结论：该研究表明，在治疗vlu和dfu患者时，使用3DFit技术从SoC过渡到单一硅胶泡沫敷料可能节省成本，而不会影响伤口管理的临床结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of wound care DERMATOLOGY-

CiteScore

2.90

自引率

10.50%

发文量

215

期刊介绍： Journal of Wound Care (JWC) is the definitive wound-care journal and the leading source of up-to-date research and clinical information on everything related to tissue viability. The journal was first launched in 1992 and aimed at catering to the needs of the multidisciplinary team. Published monthly, the journal’s international audience includes nurses, doctors and researchers specialising in wound management and tissue viability, as well as generalists wishing to enhance their practice. In addition to cutting edge and state-of-the-art research and practice articles, JWC also covers topics related to wound-care management, education and novel therapies, as well as JWC cases supplements, a supplement dedicated solely to case reports and case series in wound care. All articles are rigorously peer-reviewed by a panel of international experts, comprised of clinicians, nurses and researchers. Specifically, JWC publishes: High quality evidence on all aspects of wound care, including leg ulcers, pressure ulcers, the diabetic foot, burns, surgical wounds, wound infection and more The latest developments and innovations in wound care through both preclinical and preliminary clinical trials of potential new treatments worldwide In-depth prospective studies of new treatment applications, as well as high-level research evidence on existing treatments Clinical case studies providing information on how to deal with complex wounds Comprehensive literature reviews on current concepts and practice, including cost-effectiveness Updates on the activities of wound care societies around the world.